NEW YORK, September 4, 2014 /PRNewswire/ --
Today, Analysts Review released its research reports regarding 3D Systems Corporation (NYSE: DDD), EMC Corporation (NYSE: EMC), Skyworks Solutions Inc. (NASDAQ: SWKS), Texas Instruments Inc. (NASDAQ: TXN) and Stratasys Ltd. (NASDAQ: SSYS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6206-100free.
--
3D Systems Corporation Research Reports
On August 28, 2014, 3D Systems Corporation (3DS) announced completion of the acquisition of Ohio-based Simbionix for $120 million in cash. According to the Company, the combination of Simbionix's leading 3D surgical simulation and training tools with 3DS' clinical capabilities accelerates the creation of a personalized healthcare platform that extends from the training room to the operating room. The Company expects the acquisition to be immediately accretive to its cash generation and to its non-GAAP EPS. "The acquisition of Simbionix extends our first mover advantage in the fast growing field of 3D printing enabled personalized medicine," said Avi Reichental, President and CEO, 3DS. The full research reports on 3DS are available to download free of charge at:
http://www.analystsreview.com/Sep-04-2014/DDD/report.pdf
--
EMC Corporation Research Reports
On August 29, 2014, the stock of EMC Corporation (EMC) gained 0.41% to end the trading session at $29.53. During the session, the stock opened at $29.45, and fluctuated in the range of $29.29 - $29.60, with a total of 6.14 million shares changing hands. Shares in EMC have declined by 1.24% in the last one month, in contrast to the Dow Jones Industrial Average which rose 1.29% during that period. The full research reports on EMC are available to download free of charge at:
http://www.analystsreview.com/Sep-04-2014/EMC/report.pdf
--
Skyworks Solutions Inc. Research Reports
On August 28, 2014, Skyworks Solutions Inc. (Skyworks) announced that it received the Diamond Supplier Award from Lenovo - the highest recognition Lenovo provides to suppliers -- for providing outstanding service and support. The Company stated that the award recognizes Skyworks for being a strategic partner and playing an instrumental role in delivering low-cost, customized solutions supporting the Lenovo's recent product launches. "Skyworks is honored to receive this recognition from Lenovo, especially since it marks our second award in two consecutive years," said Bradley C. Byk, Senior Vice President of worldwide sales at Skyworks. Skyworks informed that it provides a variety of front-end solutions to Lenovo including multimode, multiband power amplifiers, antenna switches, diodes and global positioning system devices. The full research reports on Skyworks are available to download free of charge at:
http://www.analystsreview.com/Sep-04-2014/SWKS/report.pdf
--
Texas Instruments Inc. Research Reports
On August 28, 2014, Texas Instruments Inc. (TI) unveiled 46 new ultra-low-power MSP430™ FRAM microcontrollers (MCUs) with more memory, features and integration, which will allow developers to reduce power consumption, bill of materials and product size. TI informed that its MSP430FR69x MCUs are scalable up to 128 KB non-volatile FRAM memory and include smart analog integration, including an extended scan interface (ESI) and a differential input analog-to-digital converter (ADC) that consumes 140 uA at 200 KSPS. Also, the Company said that developers can leverage the integrated 320-segment LCD controller to easily add a display to their products and a 256-bit advanced encryption standard (AES) hardware accelerator to increase security of data transmissions. The integrated ESI module, differential ADC and LCD controller make MSP430FR69x MCUs suitable for smart flow metering designs for water, gas and heat. The Company informed that MSP430FR69x MCUs are now available in production quantities for $4.50 in 1K units. The full research reports on TI are available to download free of charge at:
http://www.analystsreview.com/Sep-04-2014/TXN/report.pdf
--
Stratasys Ltd. Research Reports
On August 26, 2014, Stratasys Ltd. (Stratasys) announced that twelve National Health Service (NHS) hospitals across UK experienced substantial reduction in the theatre costs due to significant decrease in the surgical procedure times with the implementation of Stratasys 3D Printing Solutions. According to the Company, the twelve NHS hospitals are being supported by UK medical 3D printing specialist, Replica 3DM, which uses Stratasys 3D printers. Stratasys stated that Replica 3DM's Stratasys Objet24 and Objet30 Pro 3D Printers convert patient CT scans into physical 3D printed models that are used as surgical guides to test implants for size and fit pre-surgery. Chris Baker, Stratasys Northern European Territory Manager, commented: "In an industry where precision is paramount, the ability to produce highly accurate 3D printed surgical models and guides that mimic the look and feel of titanium implants can both lower costs and reduce the time required for patients to be anesthetised." The full research reports on Stratasys are available to download free of charge at:
http://www.analystsreview.com/Sep-04-2014/SSYS/report.pdf
--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
